The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 650-657 , October 2007

Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo

  • So Mi Soel

      Affiliations

    • Department of Food Science and Nutrition, Dankook University, Seoul 140-714, Korea
    • ,
  • Ok Sook Choi

      Affiliations

    • Department of Food Science and Nutrition, Dankook University, Seoul 140-714, Korea
    • ,
  • Myung Hee Bang

      Affiliations

    • Department of Food Science and Nutrition, Dankook University, Seoul 140-714, Korea
    • ,
  • Jung Han Yoon Park

      Affiliations

    • Department of Food Science and Nutrition, Hallym University, Chuncheon 200-702, Korea
    • ,
  • Woo Kyoung Kim

      Affiliations

    • Department of Food Science and Nutrition, Dankook University, Seoul 140-714, Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 709 2407; fax: +82 2 792 7960.

Received 3 July 2006 ,Revised 18 October 2006 ,Accepted 20 October 2006.

References 

  1. Annual report of the Central Cancer Registry in Korea. Seoul: Ministry of Health and Welfare; 2002;
  2. de Vicente JC, Frensno MF, Vallalain L, Vega JA, Hernandez Vallejo G. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. Oral Oncol. 2005;41:283–293
  3. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993;73:161–195
  4. Matrisian L. The matrix degrading metalloproteinases. Bioessays. 1992;14:455–459
  5. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–21494
  6. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000;14(17):2123–2133
  7. Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004;49(3):179–186
  8. Kim MH, Kitson RP, Albertsson P, Nannmark U, Basse PH, Kuppen PJ, et al. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol. 2000;164:5883–5889
  9. Reddy BS. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev. 2000;9:239–247
  10. Parodi PW. Cow's milk fat components as potential anticarcinogenic agents. J Nutr. 1997;127:1055–1060
  11. Kim EJ, Kang IJ, Cho HJ, Kim WK, Ha YL, Park JH. Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J Nutr. 2003;133(8):2675–2681
  12. Ip C, Ip MM, Loftus T, Shoemaker S, Shea-Eaton W. Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prev. 2000;9:689–696
  13. Belury MA, Nickel KP, Bird CE, Wu Y. Dietary conjugated linolenic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer. 1996;26:149–157
  14. Ha YL, Storkson J, Pariza MW. Inhibition of benzo(α)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acids. Cancer Res. 1990;50:1097–1101
  15. Sebedio JL, Gnaedig S, Chardigny JM. Recent advances in conjugated linoleic acid research. Curr Opin Clin Nutr Metab Care. 1999;2:499–506
  16. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000;223(1):8–13
  17. Palombo JH, Ganguly A, Bistrian BR, Menard MP. The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett. 2002;177:163–182
  18. Kim EJ, Holthuizen PE, Park HS, Ha YL, Jung KC, Park JHY. Trans-10, cis-12 conjugated linoleic acid inhibited Caco-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol. 2005;283:G357–G367
  19. Seol SM, Bang MH, Choi OS, Park JHY, Kim WK. Effects of conjugated linoleic acid (CLA) on matrix metalloproteinases (MMP) activity and cell motility in human colon cancer cell lines. Korean J Nutr. 2003;36(3):280–283
  20. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res. 1997;17(2A):969–973
  21. Stracker ML, Engel JD, Wilson LW, Rechler MM, Loitta LA, Schiffmann E. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem. 1989;264:21544–21549
  22. Rouet-Benzineb P, Buhler JM, Dreyfus P, Delcourt A, Dorent R, Pernnec J, et al. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail. 1999;17:337–352
  23. Kwon YH, Jovanovic A, Serfas MS, Tyner AL. The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury. J Biol Chem. 2003;278:30348–30355
  24. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of the Nutrition Ad Hoc Writing Committee on the reformulation of AIN-76A rodent diet. J Nutr. 1993;123:1939–1951
  25. Huang Q, Shen HM, Ong CN. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol. 2004;68:361–371
  26. Torricelli C, Fortino V, Capurro E, Sacchi G, Ponzo P, Pacini A, et al. Role of PTHrp and PTHrp-engaged pathways in MCF-7 cells migration/invasion. Matrix Biol. 2006;25:104–111
  27. Meyer E, Vollmer JY, Bovey R, Stamenkovic I. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res. 2005;65(10):4261–4272
  28. Han SY, Lee MS, Kim HR, Baek SH, Ahn DH, Chae HS, et al. Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells. Int J Oncol. 2000;17(3):487–494
  29. Yoon SO, Kim MM, Chung AS. Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem. 2001;276:20085–20092
  30. Cho HJ, Kim EJ, Lim SS, Kim MK, Sung MK, Kim JS, et al. trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid inhibits G1-S progression in HT-29 human colon cancer cells. J Nutr. 2006;136:893–898
  31. Yang Y, Chen B, Xue Y, Zheng Y. Effects of c9, t11-conjugated linoleic acid on the metastasis of human gastric carcinoma cell line. Wei Sheng Yan Jiu. 2003;32(2):117–119
  32. Mook ORF, Frederiks WM, van Noorden CJF. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta. 2004;1705:69–89
  33. Harris MA, Hansen RA, Vidsudhiphan P, Koslo JL, Thomas JB, Watkins BA, et al. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production. Prostaglandins Leukot Essent Fatty Acids. 2001;65(1):23–29
  34. Liew C, Schut HAJ, Chin SF, Pariza MW, Dashwood RH. Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis. 1995;6:3037–3043
  35. Pariza MW, Park Y, Cook ME. Conjugated linoleic acid and the control of cancer and obesity. Toxicol Sci. 1999;52(Suppl):107–110
  36. Liu KL, Belury MA. Conjugated linoleic acid reduces arachidonic acid content and PGE2 synthesis in murine keratinocytes. Cancer Lett. 1998;127:15–22
  37. Park HS, Cho HY, Ha YL, Park JH. Dietary conjugated linoleic acid increases the mRNA ratio of Bax/Bcl-2 in the colonic mucosa of rats. J Nutr Biochem. 2004;5(4):229–235
  38. Varga J, Diaz-Perez A, Rosenbloom J, Jimenez SA. PGE2 causes a coordinate decrease in the steady-state level of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun. 1987;147:1282–1288
  39. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR, Basbaum CB, et al. Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras ERK, and NF-κB. J Biol Chem. 2002;277:32624–32631
  40. Carter CA, Kane CJ. Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem. 2004;1(21):2883–2902
  41. Heider I, Schulze B, Oswald E, Henklein P, Scheele J, Kaufman R. PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism. Oncol Res. 2004;14(10):475–482
  42. Masur K, Lang K, Niggemann B, Zanker KS, Entschladen F. High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol Biol Cell. 2001;12(7):1973–1982
  43. Huang S, Singh RK, Xie K, Gutnam M, Berry KK, Bucana CD, et al. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol Immunother. 1994;39:231–238
  44. Xie K, Bielenberq D, Huang S, Xu L, Salas T, Juang SH, et al. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide. Clin Cancer Res. 1997;31:2283–2294
  45. Hubbard NE, Lim D, Summers L, Erickson KL. Reduction of murine mammary tumor metastasis by conjugated linoleic acid. Cancer Lett. 2000;50(1):93–100
  46. Hubbard NE, Lim D, Erickson KL. Effect of separate conjugated linoleic acid isomers on murine mammary tumorigenesis. Cancer Lett. 2003;190:13–19

☆ This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (02-PJ1-PG10-22003-0001).

PII: S0955-2863(07)00007-1

doi: 10.1016/j.jnutbio.2006.10.011

The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 650-657 , October 2007

Article Tools

* Image Usage & Resolution